Your browser doesn't support javascript.
loading
Biomarkers for Predicting Abiraterone Treatment Outcome and Selecting Alternative Therapies in Castration-Resistant Prostate Cancer.
Qin, Sisi; Gao, Huanyao; Kim, Wootae; Zhang, Huan; Gu, Yayun; Kalari, Krishna R; Sinnwell, Jason P; Scholz, Jodi A; Xie, Fang; Yin, Ping; Yu, Jia; Qin, Bo; Zhuang, Yongxian; Wei, Lixuan; Tan, Winston; Bryce, Alan H; Weinshilboum, Richard M; Wang, Liewei.
Afiliação
  • Qin S; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Gao H; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Kim W; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Zhang H; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Gu Y; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Kalari KR; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Sinnwell JP; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Scholz JA; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Xie F; Department of Comparative Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Yin P; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Yu J; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Qin B; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Zhuang Y; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Wei L; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Tan W; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Bryce AH; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Weinshilboum RM; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Jacksonville, Florida, USA.
  • Wang L; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Phoenix, Arizona, USA.
Clin Pharmacol Ther ; 111(6): 1296-1306, 2022 06.
Article em En | MEDLINE | ID: mdl-35288936
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapias Complementares / Neoplasias de Próstata Resistentes à Castração Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapias Complementares / Neoplasias de Próstata Resistentes à Castração Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos